Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.40 EUR
−20.35 M EUR
9.86 M EUR
8.99 M
About HEIDELBERG PHARMA AG
Sector
CEO
Andreas Pahl
Headquarters
Ladenburg
Website
Founded
1997
ISIN
DE000A11QVV0
FIGI
BBG00NRVY3F1
Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The firm focuses on oncology; and development Amanitin, a toxin used in cancer therapies. It also offers tumor implantation models, inflammatory and autoimmune diseases, and bioanalytics services. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0QW5 is 2.30 EUR — it has decreased by −1.71% in the past 24 hours. Watch HEIDELBERG PHARMA AG NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HEIDELBERG PHARMA AG NPV stocks are traded under the ticker 0QW5.
0QW5 stock has risen by 5.99% compared to the previous week, the month change is a −9.80% fall, over the last year HEIDELBERG PHARMA AG NPV has showed a −18.15% decrease.
We've gathered analysts' opinions on HEIDELBERG PHARMA AG NPV future price: according to them, 0QW5 price has a max estimate of 11.30 EUR and a min estimate of 8.80 EUR. Watch 0QW5 chart and read a more detailed HEIDELBERG PHARMA AG NPV stock forecast: see what analysts think of HEIDELBERG PHARMA AG NPV and suggest that you do with its stocks.
0QW5 reached its all-time high on Jun 22, 2021 with the price of 8.42 EUR, and its all-time low was 2.17 EUR and was reached on Nov 12, 2024. View more price dynamics on 0QW5 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0QW5 stock is 1.74% volatile and has beta coefficient of 0.57. Track HEIDELBERG PHARMA AG NPV stock price on the chart and check out the list of the most volatile stocks — is HEIDELBERG PHARMA AG NPV there?
Today HEIDELBERG PHARMA AG NPV has the market capitalization of 104.39 M, it has decreased by −6.94% over the last week.
Yes, you can track HEIDELBERG PHARMA AG NPV financials in yearly and quarterly reports right on TradingView.
HEIDELBERG PHARMA AG NPV is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
0QW5 net income for the last quarter is −5.59 M EUR, while the quarter before that showed −4.17 M EUR of net income which accounts for −34.09% change. Track more HEIDELBERG PHARMA AG NPV financial stats to get the full picture.
No, 0QW5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 105.00 employees. See our rating of the largest employees — is HEIDELBERG PHARMA AG NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEIDELBERG PHARMA AG NPV EBITDA is −20.33 M EUR, and current EBITDA margin is −270.21%. See more stats in HEIDELBERG PHARMA AG NPV financial statements.
Like other stocks, 0QW5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEIDELBERG PHARMA AG NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEIDELBERG PHARMA AG NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEIDELBERG PHARMA AG NPV stock shows the sell signal. See more of HEIDELBERG PHARMA AG NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.